Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer

Desmond Yip*, David Goldstein

*Corresponding author for this work

    Research output: Contribution to journalComment/debatepeer-review

    3 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)236-241
    Number of pages6
    JournalCancer Treatment Reviews
    Volume31
    Issue number3
    DOIs
    Publication statusPublished - May 2005

    Cite this